Seven weeks before Merck & Co. pulled the arthritis drug Vioxx off the market because of safety concerns, federal drug regulators downplayed the significance of scientific findings citing the increased risks, documents released show.
But the U.S. Food and Drug Administration said similar prescription drugs were safe.
Merck & Co. removed Vioxx from use after new study results showed increased risk of heart attacks and stroke in people who used it for longer than 18 months.
Merck's decision to withdraw Vioxx cast suspicion on the safety of drugs in that class.
Meanwhile.
Pfizer's medical director, Dr. Gail Cawkwell, insisted that
